Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Obstet Gynaecol Res ; 45(12): 2407-2418, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31523901

ABSTRACT

AIM: To explore the involvement of Mad2 and BubR1 in cervical carcinogenesis. METHODS: The expressions of Mad2 and BubR1 in tissues of high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and chronic cervicitis were analyzed immunohistochemistrily and compared with those of p16INK4A . PEGFP-Mad2 and pEGFP-BubR1 were transfected into SiHa cells to overexpress Mad2 and BubR1 and Si-RNAs to knockdown. Cell viability was measured by cell counting kit-8 (CCK-8) assay. Migration and invasion capabilities were detected by Transwell. Propidium iodide staining with flow cytometry was used for cell cycle analysis and apoptosis was detected using Annexin V/7-AAD staining after nocodazole treatment. RESULTS: The expression of Mad2 was significantly lower in HSIL than those in chronic cervicitis and LSIL, however, the expression of BubR1 showed no significant differences. To detect HSIL in cervical lesions, Mad2 had a sensitivity of 88.44% and a specificity of 87.23%, Mad2 was less sensitive and more specific than p16INK4a . In SiHa cells, knockdown of Mad2 and BubR1 increased cell growth, reinforced invasion capacity and migration potency, inhibited apoptosis and decreased G2-phase distribution after nocodazole treatment. Oppositely, the overexpression strategies made cells show decreased malignant behaviors, raised apoptosis and increased G2-phase distribution. CONCLUSION: Mad2 negativity was specific to identify HSIL immunohistochemistrily. Downregulation of Mad2 and BubR1 increase the malignant behavior and nocodazole resistance of SiHa cells via causing spindle assembly checkpoint defect. This mechanism may contribute to cervical carcinogenesis and resistance to microtubule-targeting drugs.


Subject(s)
Antineoplastic Agents/therapeutic use , Mad2 Proteins/physiology , Nocodazole/therapeutic use , Protein Serine-Threonine Kinases/physiology , Uterine Cervical Neoplasms/drug therapy , Adult , Apoptosis/drug effects , Cells, Cultured , Cervix Uteri/chemistry , Cyclin-Dependent Kinase Inhibitor p16/analysis , Down-Regulation , Drug Resistance, Neoplasm , Female , Humans , Mad2 Proteins/analysis , Mad2 Proteins/antagonists & inhibitors , Middle Aged , Neoplasm Invasiveness , Protein Serine-Threonine Kinases/analysis , Protein Serine-Threonine Kinases/antagonists & inhibitors , Signal Transduction/drug effects , Uterine Cervical Neoplasms/pathology
2.
J Reprod Dev ; 65(1): 57-66, 2019 Feb 08.
Article in English | MEDLINE | ID: mdl-30464155

ABSTRACT

Mammalian oocyte quality degrades over time after ovulation in vitro, which can cause fatal defects such as chromosomal aneuploidy. As various oocyte manipulations employed in assisted reproductive technology are time consuming, post-ovulatory aging is a serious problem to overcome in reproductive medicine or ova research. In this study, we investigated the effects of postovulatory aging on the incidence of chromosome aneuploidy during meiosis II, with a focus on the expression of functional proteins from the spindle assembly checkpoint (SAC). Chromosome analysis was used to assess the rate of aneuploidy in in vitro aged oocytes, or in early embryos derived from aged oocytes. Immunofluorescent staining was used to detect the localization of MAD2, which is a SAC signal that monitors the correct segregation of sister chromatids. Immunoblotting was used to quantify cohesin subunits, which are adhesion factors connecting sister chromatids at the metaphase II (MII) centromere. It was shown that post-ovulatory oocyte aging inhibits MAD2 localization to the sister kinetochore. Furthermore, oocyte aging prevented cohesin subunits from being maintained or degraded at the appropriate time. These data suggest that the destabilization of SAC signaling causes sister chromatid segregation errors in MII oocytes, and consequently increases the incidence of aneuploidy in early embryos. Our findings have provided distinct evidence that the post-ovulatory aging of oocytes might also be a risk factor for aneuploidy, irrespective of maternal age.


Subject(s)
Aneuploidy , Cellular Senescence/physiology , Meiosis/physiology , Oocytes/physiology , Ovulation/physiology , Spindle Apparatus/physiology , Animals , Cell Cycle Proteins/physiology , Chromosomal Proteins, Non-Histone/physiology , Embryo, Mammalian/chemistry , Female , Fertilization in Vitro , Fluorescent Antibody Technique , In Vitro Oocyte Maturation Techniques , Kinetochores/chemistry , M Phase Cell Cycle Checkpoints/physiology , Mad2 Proteins/analysis , Male , Mice , Mice, Inbred ICR , Oocytes/chemistry , Risk Factors , Sister Chromatid Exchange/physiology , Cohesins
3.
Stem Cell Reports ; 8(4): 813-821, 2017 04 11.
Article in English | MEDLINE | ID: mdl-28330620

ABSTRACT

The chromatin of naive embryonic stem cells (ESCs) has a largely open configuration, as evident by the lack of condensed heterochromatin and the hypomethylation of DNA. Several molecular mechanisms promoting this constellation were previously identified. Here we present evidence for an important epigenetic function of MAD2L2, a protein originally known for its role in DNA damage repair, and for its requirement in germ cell development. We demonstrate using super-resolution microscopy that numerous MAD2L2 microfoci are exclusively associated with euchromatin, similar to other factors of the DNA damage response. In the absence of MAD2L2 the amount of heterochromatin demarcated by H3K9me2 was significantly increased. Among the most strongly suppressed genes was Dppa3, an ESC- and germ-cell-specific gene regulating DNA methylation. In Mad2l2-deficient ESCs 5-methylcytosine levels were globally increased, while several imprinted genes became hypomethylated and transcriptionally activated. Our results emphasize the important function of MAD2L2 for the open chromatin configuration of ESCs.


Subject(s)
Epigenesis, Genetic , Euchromatin/metabolism , Mad2 Proteins/metabolism , Mouse Embryonic Stem Cells/cytology , Repressor Proteins/genetics , Animals , Cell Line , Chromosomal Proteins, Non-Histone , DNA Damage , DNA Methylation , Down-Regulation , Euchromatin/genetics , Gene Deletion , Genetic Loci , Heterochromatin/genetics , Heterochromatin/metabolism , Mad2 Proteins/analysis , Mad2 Proteins/genetics , Mice , Mouse Embryonic Stem Cells/metabolism , Transcriptional Activation
4.
Clin Transl Oncol ; 18(6): 632-40, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26474871

ABSTRACT

PURPOSE: Oesophageal adenocarcinoma is an exemplar model of obesity-associated cancer. Locally advanced disease is treated with neoadjuvant chemoradiotherapy, and survival rates are highest in patients demonstrating a pathological response following neoadjuvant therapy. Given that 55 % of oesophageal adenocarcinoma patients are obese, uncovering the effect of adipose tissue on radioresponse is clinically relevant. This study investigates if adipose tissue activates genomic instability events in radioresponsive (OE33P) and radioresistant (OE33R) oesophageal cancer cell lines and tumour samples. METHODS: OE33R and OE33P were cultured with adipose-conditioned media derived from oesophageal adenocarcinoma patients (n = 10). Anaphase bridges, a marker of genomic instability, were enumerated in both cell lines following treatment with adipose media, and normalised to cell number. Genomic instability is regulated by the spindle assembly complex. Expression of two spindle assembly complex genes (MAD2L2, BUB1B) was assessed using qPCR, and validated in patient tumour specimens from viscerally obese (n = 46) and nonobese patients (n = 41). RESULTS: Adipose-conditioned media increased anaphase bridging in OE33R (p < 0.0001), with a threefold increase in OE33R compared to OE33P (p < 0.01). Levels of anaphase bridges in OE33R cells correlated with visceral obesity status as measured by waist circumference (R = 0.709, p = 0.03) and visceral fat area (R = 0.794, p = 0.006). Adipose tissue altered expression of MAD2L2 in vitro. In vivo, MAD2L2 expression was higher in viscerally obese oesophageal adenocarcinoma patients compared with nonobese patients (p < 0.05). CONCLUSIONS: Anaphase bridge levels are influenced by obesity and radiosensitivity status in oesophageal adenocarcinoma. Furthermore, visceral adipose-conditioned media stimulates dysregulation of the spindle assembly complex in oesophageal adenocarcinoma patients.


Subject(s)
Adenocarcinoma/pathology , Cell Transformation, Neoplastic/genetics , Esophageal Neoplasms/pathology , Obesity, Abdominal/complications , Radiation Tolerance/genetics , Adenocarcinoma/genetics , Aged , Anaphase/genetics , Cell Cycle Proteins/analysis , Cell Cycle Proteins/biosynthesis , Cell Transformation, Neoplastic/pathology , Esophageal Neoplasms/genetics , Genomic Instability , Humans , M Phase Cell Cycle Checkpoints/genetics , Mad2 Proteins/analysis , Mad2 Proteins/biosynthesis , Male , Middle Aged , Protein Serine-Threonine Kinases/analysis , Protein Serine-Threonine Kinases/biosynthesis , Real-Time Polymerase Chain Reaction
5.
Int J Hematol ; 102(6): 662-9, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26449786

ABSTRACT

REV7 is a multifunctional protein involved in DNA damage tolerance, cell-cycle regulation, gene expression, and carcinogenesis. Although its expression is reportedly associated with poor prognosis in human solid tissue cancers, the significance of REV7 expression in hematopoietic malignancies is unclear. This study evaluated the prognostic significance of REV7 expression in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab-combined chemotherapy. Using immunohistochemistry, we analyzed 83 specimens of de novo DLBCL [38 germinal center B-cell-like (GCB) and 45 non-GCB DLBCLs] treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone for REV7 expression. Aberrant REV7 expression was detected in DLBCL cell nuclei. High REV7 expression was associated with significantly shorter overall survival (OS) and progression-free survival (PFS) using Kaplan-Meier analysis and log-rank tests (P < 0.01 and P < 0.01, respectively). Multivariate analysis revealed that REV7 expression is an independent prognostic factor for both OS and PFS. Additionally, when patients were divided into four groups using a combination of REV7 expression and international prognostic index (IPI) or Bcl-2 expression, REV7(High)/IPI(Poor) and REV7(High)/Bcl-2(High) patients showed the poorest outcome. These results indicate that REV7 may be a useful biomarker to predict the prognosis of patients with DLBCL treated with rituximab.


Subject(s)
Antineoplastic Agents/therapeutic use , Gene Expression , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/drug therapy , Mad2 Proteins/analysis , Rituximab/therapeutic use , Adult , Aged , Aged, 80 and over , Biomarkers/analysis , Female , Humans , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/mortality , Mad2 Proteins/genetics , Male , Middle Aged , Nuclear Proteins/analysis , Nuclear Proteins/genetics , Nucleotidyltransferases/analysis , Nucleotidyltransferases/genetics , Prognosis , Retrospective Studies , Survival Rate , Young Adult
6.
J Natl Cancer Inst ; 107(10)2015 Oct.
Article in English | MEDLINE | ID: mdl-26286589

ABSTRACT

BACKGROUND: Accurate survival stratification in early-stage non-small cell lung cancer (NSCLC) could inform the use of adjuvant therapy. We developed a clinically implementable mortality risk score incorporating distinct tumor microenvironmental gene expression signatures and clinical variables. METHODS: Gene expression profiles from 1106 nonsquamous NSCLCs were used for generation and internal validation of a nine-gene molecular prognostic index (MPI). A quantitative polymerase chain reaction (qPCR) assay was developed and validated on an independent cohort of formalin-fixed paraffin-embedded (FFPE) tissues (n = 98). A prognostic score using clinical variables was generated using Surveillance, Epidemiology, and End Results data and combined with the MPI. All statistical tests for survival were two-sided. RESULTS: The MPI stratified stage I patients into prognostic categories in three microarray and one FFPE qPCR validation cohorts (HR = 2.99, 95% CI = 1.55 to 5.76, P < .001 in stage IA patients of the largest microarray validation cohort; HR = 3.95, 95% CI = 1.24 to 12.64, P = .01 in stage IA of the qPCR cohort). Prognostic genes were expressed in distinct tumor cell subpopulations, and genes implicated in proliferation and stem cells portended poor outcomes, while genes involved in normal lung differentiation and immune infiltration were associated with superior survival. Integrating the MPI with clinical variables conferred greatest prognostic power (HR = 3.43, 95% CI = 2.18 to 5.39, P < .001 in stage I patients of the largest microarray cohort; HR = 3.99, 95% CI = 1.67 to 9.56, P < .001 in stage I patients of the qPCR cohort). Finally, the MPI was prognostic irrespective of somatic alterations in EGFR, KRAS, TP53, and ALK. CONCLUSION: The MPI incorporates genes expressed in the tumor and its microenvironment and can be implemented clinically using qPCR assays on FFPE tissues. A composite model integrating the MPI with clinical variables provides the most accurate risk stratification.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Non-Small-Cell Lung/chemistry , Carcinoma, Non-Small-Cell Lung/mortality , Lung Neoplasms/chemistry , Lung Neoplasms/mortality , Transcriptome , Adult , Aged , Apoptosis Regulatory Proteins/analysis , Carcinoma, Non-Small-Cell Lung/pathology , Cell Adhesion Molecules/analysis , DNA-Binding Proteins/analysis , Datasets as Topic , Female , Flow Cytometry , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Germinal Center Kinases , Glucose Transporter Type 1/analysis , Histocompatibility Antigens Class I/analysis , Histone Demethylases/analysis , Humans , Kaplan-Meier Estimate , Keratin-6/analysis , Lung Neoplasms/pathology , Lutheran Blood-Group System/analysis , Mad2 Proteins/analysis , Male , Middle Aged , Neoplasm Staging , Nuclear Proteins/analysis , Polymerase Chain Reaction/methods , Predictive Value of Tests , Prognosis , Protein Serine-Threonine Kinases/analysis , Receptors, Fc/analysis , SEER Program , United States/epidemiology
7.
Oral Dis ; 21(6): 713-20, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25754611

ABSTRACT

OBJECTIVES: BubR1 and Mad2 are central components of the mitotic checkpoint complex that inhibits anaphase onset until all chromosomes are correctly aligned at the metaphase plate. We propose to analyse the combined expression of BubR1 and Mad2 and assess its significance to oral squamous cell carcinoma (OSCC) diagnosis and prognosis. MATERIALS AND METHODS: BubR1 and Mad2 expression was assessed by real-time PCR in OSCC cell lines and in normal human oral keratinocytes, and by immunohistochemistry in 65 patients with OSCC. The results were compared regarding clinicopathological parameters, proliferative activity and survival. RESULTS: BubR1 and Mad2 transcripts were overexpressed in OSCC cell lines which also exhibited attenuated spindle assembly checkpoint activity. BubR1 and Mad2 were also overexpressed in patients with OSCC. BubR1 expression was associated with advanced stages and larger tumour size in univariate analysis, and with shorter overall survival both in univariate and multivariate analysis. Mad2 overexpression was associated with that of BubR1 and, importantly, high expression of Mad2 and BubR1 was associated with increased cellular proliferation. CONCLUSION: Our data propose a role for BubR1 and Mad2 in OSCC cellular proliferation, progression and prognosis.


Subject(s)
Carcinoma, Squamous Cell/chemistry , Mad2 Proteins/analysis , Mouth Neoplasms/chemistry , Protein Serine-Threonine Kinases/analysis , RNA, Messenger/metabolism , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Proliferation , Female , Gene Expression , Humans , Keratinocytes/metabolism , M Phase Cell Cycle Checkpoints/genetics , Mad2 Proteins/genetics , Male , Middle Aged , Mouth Neoplasms/genetics , Mouth Neoplasms/pathology , Protein Serine-Threonine Kinases/genetics , Survival Rate
8.
J Clin Pathol ; 68(5): 381-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25637637

ABSTRACT

AIMS: To study the immunoexpression of proteins related to the mitotic checkpoint (cell division cycle 20 (CDC20), mitotic arrest deficient 2 (MAD2)) and the mitotic spindle (Aurora-B) in patients with myelodysplastic syndrome (MDS). METHODS: Protein expression was analysed in bone marrow tissue samples from 40 patients with MDS using immunohistochemistry. Prognostic markers (transfusion dependency, depth of cytopenias, chromosomal abnormalities and survival) were also studied. RESULTS: Higher MAD2 expression was observed among patients with platelets <50×10(9)/L than among patients with platelets ≥50×10(9)/L (42.6±22.8% vs 22.7±19.1%, respectively). Higher CDC20 expression was identified among patients with three dysplasias compared with patients who presented with one or two dysplasias (33.9±24.1% vs 10.5±5.7% vs 12.8±7.8%, respectively), among patients who exhibited a complex versus non-complex karyotype (50.0±30.2% vs 18.4±14%, respectively) and among patients with platelets <50×10(9)/L vs platelets ≥50×10(9)/L (38.2±26.2% vs 16.1±12.4%, respectively). Higher Aurora-B expression was found in patients with an abnormal versus normal karyotype (21.2±13.2% vs 7.5±5.0%, respectively). High expression of MAD2 and CDC20 (≥50%) was associated with severe thrombocytopenia. We also found statistically significant differences in the overall survival rate when comparing different degrees of CDC20, MAD2 and Aurora-B protein expression. CONCLUSIONS: To the best of our knowledge, this is the first report to demonstrate that these proteins are associated with chromosomal abnormalities and poor prognosis in patients with MDS.


Subject(s)
Aurora Kinase B/analysis , Bone Marrow/chemistry , Cdc20 Proteins/analysis , Chromosomal Instability , M Phase Cell Cycle Checkpoints , Mad2 Proteins/analysis , Myelodysplastic Syndromes/metabolism , Spindle Apparatus/chemistry , Adolescent , Adult , Aged , Aged, 80 and over , Bone Marrow/pathology , Chromosome Banding , Female , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Karyotype , Male , Middle Aged , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/mortality , Myelodysplastic Syndromes/pathology , Platelet Count , Prognosis , Retrospective Studies , Thrombocytopenia/blood , Thrombocytopenia/genetics , Thrombocytopenia/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...